论文部分内容阅读
目的:探讨与研究将炎琥宁联合头孢曲松钠应用于治疗小儿急性肺炎的临床疗效和价值。方法:将我院收治的小儿急性肺炎患者共225例纳入研究并随机分为观察组和对照组,对照组在使用临床常规治疗的同时使用头孢曲松钠治疗,观察组在常规治疗的基础上使用头孢曲松钠联合炎琥宁治疗。观察并比较两组患儿临床症状缓解情况及临床治疗有效率。结果:观察组临床症状缓解情况及临床治疗疗效明显优于对照组,统计分析差异有统计学意义,P<0.05。结论:临床治疗小儿急性肺炎中使用炎琥宁联合头孢曲松钠治疗,可较好的缓解患儿临床症状及体征,具有较高的临床治疗效果,值得临床推广。
Objective: To investigate and study the clinical efficacy and value of combining mesylate with ceftriaxone in the treatment of acute pneumonia in children. Methods: A total of 225 cases of children with acute pneumonia admitted to our hospital were enrolled in the study and randomly divided into observation group and control group. The control group was treated with ceftriaxone sodium while using routine clinical treatment. On the basis of routine treatment, The use of ceftriaxone combined with memantine treatment. Observed and compared the clinical symptoms of children in two groups and the clinical treatment of effective rate. Results: The clinical symptom relief and clinical curative effect in the observation group were significantly better than those in the control group. The statistical analysis showed significant difference (P <0.05). Conclusion: The clinical treatment of children with acute pneumonia using the combination of mesylate and ceftriaxone sodium can better alleviate the clinical symptoms and signs in children with high clinical efficacy, worthy of clinical promotion.